Originally published by our sister publication Infectious Disease Special Edition
The CDC’s Advisory Committee on Immunization Practices (ACIP) recently voted to recommend the 20-valent pneumococcal conjugate vaccine (PCV-20) that covers 20 serotypes of Streptococcus pneumoniae (Prevnar 20, Pfizer) for routine use to help protect infants and children from invasive pneumococcal disease (IPD) from one of those serotypes and for the prevention of acute otitis media caused by the original